I re-watched The proactive interview. NP seems to emphasize the results of the Brazil trial over everything else in terms getting an approval. I guess that means that the activities in the Philippines can lead to revenue via CSP, but don’t include a trial that would lead to approval? If they did, I would think he would reference upcoming results in Philippines.

I’m not a doc or scientist, so I’m ignorant on these things But my point is, does that mean that we need to track the timetable for the Brazil trials to figure out when we might see a real approval that could apply to other countries also?